Engflag
Advertisements

Rhofade Cream

Quick links to important sections

Rhofade Cream

Rhofade Cream_FR
Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Rhofade Cream

Defining Rhofade Cream: A Topical Vasoconstrictor

Property Description
Active ingredient Oxymetazoline Hydrochloride
Form Cream (Topical)
Pharmacological class Adrenergic Agonist / Vasoconstrictor
General purpose Reducing persistent facial redness (erythema)
Origin Synthetic (Imidazole derivative)

Rhofade Cream is a specialized prescription medicine formulated for topical use on the skin, primarily classified as an Adrenergic Agonist and, functionally, as a Vasoconstrictor. This preparation is engineered specifically as a cream, a distinct dermatological dosage form designed for localized absorption, separating it from other common mucosal or ophthalmic applications of the same chemical compound. Its use is limited to dermatologic application, reflecting a highly targeted approach that has been recognized in clinical practice.

The Active Ingredient: Oxymetazoline Hydrochloride (INN)

The sole active ingredient in this topical product is Oxymetazoline Hydrochloride, a synthetic chemical compound that is classified as an imidazole derivative. This medication is considered a single-component product.

The drug is a potent, selective alpha1A-adrenoceptor agonist, which is the mechanism that drives its intended effect. This means the chemical structure is designed to interact specifically with receptors that control the tightening of blood vessels. The Oxymetazoline Hydrochloride molecule is the element responsible for the drug's action, working by interacting with receptors on blood vessel walls. This composition establishes it firmly as a pharmaceutical agent.

What Is the General Purpose of Rhofade Cream?

The general therapeutic purpose of Rhofade Cream is to help visibly lessen the appearance of persistent facial erythema, commonly known as facial redness. The cream achieves this by utilizing its function as a vasoconstrictor, which is a high-level term for a substance that causes blood vessels to constrict or tighten. This effect reduces the excess cutaneous blood flow near the skin's surface, thus addressing the underlying vascular cause of the visible redness and providing its general benefit. The focused action helps minimize the appearance of redness associated with certain dermatologic conditions in adult patients, a primary target audience within clinical use.

Regulatory References

  1. Oxymetazoline Topical Drug Information
Advertisements

What side effects are possible with Rhofade Cream?

Possible Side Effects and Safety Information

Rhofade (oxymetazoline hydrochloride) Cream, 1%, is a prescription medication used for the topical treatment of persistent facial erythema associated with rosacea. As with any medication, it may cause side effects, primarily at the application site.

Common Application Site Reactions

In clinical studies, the most common side effects reported by patients (with an incidence of ge 1%) were localized to the application area on the face. These reactions were generally mild to moderate and included:

Adverse Reaction Incidence Rate (approx.)
Application site dermatitis 2%-3%
Worsening inflammatory lesions of rosacea 1%-3%
Application site pruritus (itching) 1%-2%
Application site erythema (redness) 1%-2%
Application site pain 1%-2%

Some patients may also experience allergic reactions to the cream, which may range from a mild rash to severe symptoms requiring immediate medical attention, such as swelling of the face or difficulty breathing.

Warnings and Precautions

Rhofade Cream contains oxymetazoline, an alpha-adrenergic agonist, which can impact blood pressure. The cream should be used with caution in patients with certain pre-existing conditions, as it may worsen them. These conditions include:

  • Cardiovascular Disease: Severe, unstable, or uncontrolled heart, blood vessel, or blood pressure problems (hypertension/hypotension).
  • Vascular Insufficiency: Conditions affecting blood circulation, such as Raynaud's phenomenon, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome.
  • Glaucoma: Specifically narrow-angle glaucoma, as the medication may increase the risk of acute angle-closure glaucoma.

Patients should inform their healthcare provider about all pre-existing medical conditions, including if they are pregnant, plan to become pregnant, or are breastfeeding. It is not known if Rhofade Cream will harm an unborn baby or if it passes into breast milk.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The official overdose information for Rhofade Cream (oxymetazoline hydrochloride) is strictly centered on the risks associated with accidental oral ingestion of the product, as it is a topical medicine not intended for swallowing. The U.S. Food and Drug Administration (FDA) Prescribing Information emphasizes the potential for systemic effects stemming from this route of exposure.

Documented Overdose Manifestations

If oral ingestion occurs, the active ingredient belongs to a class of compounds (imidazoline derivatives) that have been linked to serious adverse events. Officially documented manifestations include:

  • Cardiovascular Effects: Tachycardia (fast heart rate), Bradycardia (slow heart rate), Hypertension, and Hypotension.
  • Central Nervous System Effects: Lethargy and Sedation.
  • Other Symptoms: Nausea, vomiting, and decreased respiration (slow or shallow breathing).

Required Emergency Actions

Regulators provide explicit instructions regarding when to seek urgent medical attention, particularly concerning ingestion:

Situation Action Mandated by Label
Oral Ingestion by Anyone Get medical help right away (immediate action required).
General Overdose Event Monitor patient closely and administer appropriate supportive measures as necessary.

Accidental ingestion of related compounds in children has resulted in serious adverse events requiring hospitalization, underscoring the necessity of seeking medical advice without delay if the cream is swallowed.

Advertisements

Therapeutic Uses of Rhofade Cream

Rhofade Cream is commonly used to help with symptoms that may become intense or disruptive associated with a chronic skin condition. This medication is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.

It is relevant for easing symptoms related to heightened physiological activity—namely, increased cutaneous blood flow—which interfere with daily functioning. The core use is relevant for managing symptoms that interfere with daily comfort, focusing on the fixed, ongoing redness. This application is considered relevant when supportive symptom management is appropriate, helping patients cope more steadily with symptom fluctuations.

The medication's primary therapeutic benefits include assisting with the management of symptoms related to localized discomfort, symptoms that become more disruptive during flare-ups, and the overall symptom burden of the chronic condition.

“This application generally helps ease distress and assists with maintaining functional stability when symptoms are more noticeable.”

Quick Fact: Relief for Persistent Facial Erythema

Support for Long-Term Dermatological Stability

Rhofade Cream is applied in conditions characterized by periods of heightened symptoms (rosacea) to support the management of the vascular-related symptoms. Its use assists with maintaining functional stability, which contributes to improved comfort during periods of heightened symptoms.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Rhofade Cream?

Eligibility for Rhofade Cream (oxymetazoline hydrochloride topical cream, 1%) is determined by official regulatory documents, primarily based on age and pre-existing health conditions.

Contraindications and Restrictions

Contraindications (Must Not Use)

Rhofade Cream is contraindicated in individuals with a known history of hypersensitivity (allergy) to oxymetazoline hydrochloride or any other component found in the cream formulation.

Age-Related Eligibility

Population Regulatory Status
Adults (18 years and older) Approved and Indicated
Pediatric Patients (<18) Safety and effectiveness not established

Conditions Requiring Caution

Use of Rhofade Cream requires caution in patients with specific conditions due to its mechanism as an alpha-adrenergic agonist. These conditions include severe or unstable cardiovascular disease, uncontrolled hypertension or hypotension, and narrow-angle glaucoma.

Caution is also advised for patients with cerebral or coronary insufficiency and those with conditions that predispose them to vascular insufficiency, such as Raynaud's phenomenon.

Pregnancy and Lactation

Official labeling states there are no adequate data available in pregnant women to inform a drug-associated risk, and it is unknown if the medicine is distributed into human breast milk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Rhofade Cream contains oxymetazoline, an alpha-adrenergic agonist, which can be absorbed systemically in small amounts. Therefore, caution is advised when using it concurrently with certain medications that affect blood pressure or the cardiovascular system, as the risk of increased sympathetic (adrenergic) effects may occur.

Medications to Discuss with Your Healthcare Provider

It is important to inform your healthcare provider about all prescription, over-the-counter (OTC) medicines, vitamins, herbal supplements, and other topical skin products you use. Particular caution is necessary with the following classes of drugs:

  • Monoamine Oxidase Inhibitors (MAOIs): Concurrent use is not recommended due to the potential for an increase in systemic exposure to circulating amines, which can affect blood pressure and heart rate.
  • Anti-hypertensives/Cardiac Glycosides: This includes medications used to manage high blood pressure (such as beta-blockers and calcium-channel blockers), and cardiac glycosides like digoxin. Rhofade Cream may affect the efficacy or increase the side effects of these medications.
  • Alpha-1 Adrenergic Receptor Antagonists: Used for conditions like cardiovascular disease or benign prostatic hypertrophy (BPH), these drugs (e.g., alfuzosin, doxazosin) may interact with the oxymetazoline in Rhofade Cream.

Other Topical Products

Generally, applying other topical products, moisturizers, or sunscreens is permissible; however, Rhofade Cream should be applied first and allowed to absorb before applying other products. Avoid applying the cream to irritated skin or open wounds, as this may increase the amount of drug absorbed and potentially increase the risk of side effects.

Advertisements

Mechanism of Action

How Rhofade Cream Works

Molecular Mechanism: alpha1A-Adrenoceptor Agonism

The mechanism of action for Rhofade Cream is confined to the pharmacodynamics of its active ingredient, Oxymetazoline Hydrochloride. The molecule functions as a selective agonist by binding to and activating the alpha1A-adrenoceptors located on the vascular smooth muscle cells (VSMCs) of the dermal blood vessels. This interaction initiates a specific signaling cascade characteristic of alpha1-adrenoceptor activation.

Physiological Mechanism: Gq/ PLC Cascade and Vascular Tone Modulation

Activation of the alpha1A-adrenoceptor triggers the Gq/ PLC signaling cascade, leading to the mobilization of intracellular calcium ions ( Ca^2+) within the VSMCs. The consequent rise in Ca^2+ causes the VSMCs to contract, a process known as vasoconstriction. This contraction physically reduces the flow and volume of blood in the superficial capillaries and venules, thereby altering the vascular tone. This physiological action is the end result of the alpha1A-adrenoceptor signaling pathway.

Advertisements

Dosage and Administration Information

How to Use Rhofade Cream

Rhofade (oxymetazoline hydrochloride) Cream, 1.0% is a prescription medication approved for the topical treatment of persistent facial redness (erythema). The administration instructions are precise and must be followed as directed to ensure proper use.

Official Administration Guidelines

Category Instruction
Route of Administration Topical (application to the skin). This preparation is for dermatologic use only.
Dosing Schedule Apply a pea-sized amount of the 1.0% cream.
Frequency Apply the cream once daily.
Application Area The cream should be applied to the entire face (forehead, nose, cheeks, and chin).

Key Procedural Instructions

Adherence to the correct application technique is essential for standardized use:

  • Target Areas: The pea-sized amount must be spread evenly over the entire facial area designated for treatment.
  • Areas to Avoid: Application to the eyes and lips must be avoided.
  • Hand Washing: Patients should wash their hands immediately after applying the cream.

Population-Specific Guidance

No dose adjustment is required for geriatric patients (65 years and older). The safety and effectiveness of Rhofade Cream in pediatric patients (under 18 years of age) have not been established. There are no specified dosage modifications for patients with renal or hepatic impairment.

Advertisements

Recent Clinical Evidence

Rhofade Cream: Recent Clinical Evidence

The clinical profile of Rhofade (oxymetazoline hydrochloride) cream 1.0% is supported by clinical trials that primarily investigated its utility in treating persistent facial redness associated with rosacea in adults.

Mechanism Explored in Studies

Studies have evaluated the compound's intended mechanism of action, which involves the compound's effect as an alpha-1A adrenoceptor agonist. This action was assessed for its influence on the appearance of facial blood vessels.

Initial research also examined whether the compound was associated with changes in the appearance of facial redness and the severity of symptoms over short timeframes.

Clinical Trial Results: Key Efficacy Endpoints

The key evidence is derived from two randomized, double-blind, placebo-controlled Phase 3 trials involving adult patients with moderate-to-severe persistent facial erythema.

Study Phase Primary Outcome Measure Result Type
Phase 3 Trials (Two) 2-grade reduction in facial erythema score at 3 hours post-dose (Day 29) Binary Response

In both Phase 3 trials, researchers reported that a higher percentage of patients receiving the cream achieved the primary outcome measure compared to those in the placebo group. The trials assessed the redness response at 3 and 6 hours after application on Day 1 and maintained assessment through Day 29.

Safety and Tolerability Profile

Safety was monitored across all phases of clinical development, with adverse events recorded. The most common adverse events reported in the studies included application site dermatitis, worsening of inflammatory lesions of rosacea, application site pruritus (itching), and erythema (redness).

Research assessed the tolerability of the compound in adult patients throughout the study periods. Details regarding potential interactions and contraindications are available in the complete regulatory information.

Key Studies & References Rosacea: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Rhofade Cream (FAQ)

Q: What is Rhofade Cream used for?

A: Rhofade (oxymetazoline hydrochloride) Cream, 1% is a prescription medicine used on the skin (topical) to treat persistent facial erythema (redness) associated with rosacea in adults.

Q: How should I apply Rhofade Cream?

A: Apply a pea-sized amount of Rhofade Cream to the entire face, avoiding the eyes and lips, once daily in the morning. Use it only as directed by your healthcare provider. Wash your hands immediately after applying the cream.

Q: What are the most common side effects of Rhofade Cream?

A: The most common side effects reported with Rhofade Cream are:

  • Application site reactions, such as temporary irritation, itching (pruritus), redness (erythema), and pain.
  • Worsening of inflammatory lesions (pimples) of rosacea.

These side effects are usually mild to moderate and often decrease with continued use. Tell your doctor about any side effect that bothers you or that doesn't go away.

Q: What should I do if I miss a dose of Rhofade Cream?

A: If you miss a dose of Rhofade Cream, skip the missed dose and apply the next dose at the usual time the following morning. Do not apply extra cream to make up for the missed dose.

Q: Can Rhofade Cream cause rebound redness or worsening of rosacea after stopping treatment?

A: Some patients have reported transient worsening of erythema (redness) and inflammatory lesions (pimples) after stopping Rhofade Cream. You should discuss with your healthcare provider how to stop using the medicine if you wish to discontinue treatment.

Q: Can I use other topical products or makeup with Rhofade Cream?

A: Yes, you can use cosmetics and other topical products. Apply Rhofade Cream first, let it dry completely, and then apply other products like moisturizer or makeup. Always follow your healthcare provider's instructions regarding the use of other products.

Q: Is Rhofade Cream safe to use during pregnancy or while breastfeeding?

A: It is not known if Rhofade Cream can harm an unborn baby or if the medicine passes into breast milk. If you are pregnant, plan to become pregnant, or are breastfeeding, you should talk to your doctor about the risks and benefits of using Rhofade Cream.

Q: How long does it take for Rhofade Cream to start working?

A: Rhofade Cream can start to reduce facial redness as soon as 3 to 6 hours after the first application. The maximum effect is often seen after about 12 hours. Continued daily use is necessary to maintain the reduction in redness.

Advertisements

How should Rhofade Cream be stored and disposed of?

How to Store and Dispose of Rhofade Cream

RHOFADE (oxymetazoline hydrochloride) cream, 1%, must be stored under specific environmental conditions as defined by regulatory labeling to maintain stability.

Storage Requirements

The cream must be stored at controlled room temperature, which is between 68^circF and 77^circF (20^circC and 25^circC). Permitted temperature excursions are between 59^circF and 86^circF (15^circC and 30^circC).

  • Handling: The official labeling instructs to keep the tube tightly closed when not in use and cautions against freezing the product.
  • Child Safety: It is mandatory to keep Rhofade cream and all medicines out of the reach of children.

Disposal Instructions

Unused or expired Rhofade cream should be disposed of properly. Regulatory guidance instructs patients to consult a healthcare professional, such as a pharmacist, or utilize an authorized drug take-back program. Unless specifically instructed otherwise, do not flush unused medicine down a toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Rhofade Cream found in:

A-Z Index: